Healthcare AI Daily Briefing

Research & Evidence

XGBoost predicts mortality in sepsis-induced coagulopathy.

Journal article

In a multicenter cohort study, the XGBoost model achieved superior accuracy and generalizability in predicting early mortality in patients with sepsis-induced coagulopathy, outperforming traditional clinical scoring systems for 28-day mortality prediction. [1]

Policy & Governance

Interview: 80% of routine patient emails could be auto‑replied with human‑in‑the‑loop.

Podcast from Claims Denied

A Hospitalogy Podcast: The interview describes that about eighty percent of in‑box messages physicians receive between visits—such as prescription refills, appointment requests, or referrals—could be answered automatically with a human in the loop for monitoring or feedback, leaving twenty percent for clinicians to focus on higher‑value tasks. [2]

Policy & Governance

Survey shows 30% of AI proofs of concept reach production in US healthcare.

An opinion piece by Jost-Vincent Steiskal cites a survey of over 400 U.S. healthcare leaders indicating that only 30% of completed AI proofs of concept had progressed to production, underscoring a gap in moving beyond pilot stages. [6]

Policy & Governance

Interview: Bias can persist in AI even with correct math if proxies are flawed.

Podcast from KFF's The Business of Health with Chip Kahn

The interview describes earlier research showing an Optum acuity algorithm used cost as a proxy for sickness, producing biased results against Black patients despite accurate math, illustrating that postmarket monitoring must examine underlying assumptions, not just model performance. [4]

Clinical Practice

Continuous remote monitoring did not significantly reduce 30-day readmissions in heart failure patients.

Journal article

In a case-versus-retrospective-propensity-matched study of 39 heart failure patients, continuous remote monitoring with wearable biosensors and machine-learning alerts showed no significant difference in adjusted 30-day readmission rates between intervention and control groups. [3]

Industry & Products

Medallion acquires Andros to create largest AI‑native credentialing platform.

Medallion’s acquisition of Andros adds over one million providers across nearly 400 health organizations to its AI‑assisted credentialing platform, claiming to become the nation’s largest AI‑native credentialing service and to unify enrollment, licensing and provider data management under one system. [5]